2025
SJR Q2
JCR Q3 · 2,5
127 eşleşen makale
SCIE
Dergi ayrıntısı
Clinical and Experimental Pharmacology and Physiology
- Yayıncı
- Wiley-Blackwell Publishing Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0305187014401681
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,63
- Quartile Q2
- H-Index 121
- Atıf/yayın 2,72
- Doküman (3y) 295
- Atıf (3y) 825
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,5
- 5Y JIF 2,5
- JCI 0,79
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Pharmacology Q2
- Physiology Q3
- Physiology (medical) Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Pharmacology & Pharmacy | Physiology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,63 | 2,5 | 2,5 | 0,79 | Q2 | 121 |
| 2024 | Q2 | Q2 | 0,625 | 2,5 | 2,3 | 0,74 | Q2 | 118 |
| 2023 | Q2 | Q2 | 0,61 | 2,4 | 2,4 | 0,75 | Q2 | 118 |
| 2022 | Q2 | Q2 | 0,65 | 2,9 | 2,8 | 0,75 | Q2 | 118 |
| 2021 | Q2 | Q3 | 0,584 | 3 | 2,9 | 0,71 | Q2 | 118 |
| 2020 | Q2 | Q3 | 0,752 | 2,6 | 2,8 | 0,73 | Q2 | 118 |
| 2019 | Q2 | Q3 | 0,769 | 2,5 | 2,4 | 0,79 | Q2 | 118 |
| 2018 | — | Q3 | — | 2,3 | 2,3 | 0,73 | Q2 | — |
| 2017 | Q2 | Q3 | 0,759 | 2,1 | 2,3 | 0,73 | Q2 | 118 |
| 2016 | Q2 | Q3 | 0,845 | 2 | 2,3 | — | — | 118 |
| 2015 | Q2 | Q3 | 0,978 | 2 | 2 | — | — | 118 |
| 2014 | Q2 | Q2 | 1,042 | 2,4 | 2,1 | — | — | 118 |
| 2013 | Q2 | Q2 | 0,957 | 2,4 | 2,1 | — | — | 118 |
| 2012 | Q2 | Q3 | 0,779 | 2,2 | 2 | — | — | 118 |
| 2011 | Q2 | Q3 | 0,756 | 1,9 | 2 | — | — | 118 |
| 2010 | Q2 | Q3 | 0,832 | 2 | 2,2 | — | — | 118 |
| 2009 | — | Q3 | — | 1,9 | 2,1 | — | — | — |
| 2008 | — | Q3 | — | 2,2 | 2 | — | — | — |
| 2007 | — | Q2 | — | 2 | 2 | — | — | — |
| 2006 | — | Q3 | — | 1,8 | — | — | — | — |
| 2005 | — | Q3 | — | 1,4 | — | — | — | — |
| 2004 | — | Q2 | — | 1,7 | — | — | — | — |
| 2003 | — | Q2 | — | 1,7 | — | — | — | — |
| 2002 | — | Q3 | — | 1,5 | — | — | — | — |
| 2001 | — | Q2 | — | 1,4 | — | — | — | — |
| 2000 | — | Q2 | — | 1,5 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q2 | — | 1,1 | — | — | — | — |
| 1997 | — | Q3 | — | 0,9 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 205/356 |
| 2025 | PHYSIOLOGY | SCIE | Q3 | Q2 | 48/89 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/352 |
| 2024 | PHYSIOLOGY | SCIE | Q2 | Q3 | 37/87 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 188/354 |
| 2023 | PHYSIOLOGY | SCIE | Q2 | Q3 | 42/85 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 163/278 |
| 2022 | PHYSIOLOGY | SCIE | Q2 | Q3 | 37/79 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/279 |
| 2021 | PHYSIOLOGY | SCIE | Q3 | Q3 | 41/81 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 192/276 |
| 2020 | PHYSIOLOGY | SCIE | Q3 | Q2 | 49/81 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 158/271 |
| 2019 | PHYSIOLOGY | SCIE | Q3 | Q2 | 41/81 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 154/267 |
| 2018 | PHYSIOLOGY | SCIE | Q3 | Q3 | 44/81 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 161/261 |
| 2017 | PHYSIOLOGY | SCIE | Q3 | Q3 | 51/83 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 161/257 |
| 2016 | PHYSIOLOGY | SCIE | Q3 | — | 52/84 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 154/255 |
| 2015 | PHYSIOLOGY | SCIE | Q3 | — | 48/83 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 126/255 |
| 2014 | PHYSIOLOGY | SCIE | Q2 | — | 41/83 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 118/256 |
| 2013 | PHYSIOLOGY | SCIE | Q2 | — | 38/81 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 132/261 |
| 2012 | PHYSIOLOGY | SCIE | Q3 | — | 41/80 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 149/261 |
| 2011 | PHYSIOLOGY | SCIE | Q3 | — | 50/79 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 142/252 |
| 2010 | PHYSIOLOGY | SCIE | Q3 | — | 47/78 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 143/237 |
| 2009 | PHYSIOLOGY | SCIE | Q3 | — | 44/75 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 117/219 |
| 2008 | PHYSIOLOGY | SCIE | Q3 | — | 38/74 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 107/205 |
| 2007 | PHYSIOLOGY | SCIE | Q2 | — | 39/78 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 108/199 |
| 2006 | PHYSIOLOGY | SCIE | Q3 | — | 42/78 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 120/193 |
| 2005 | PHYSIOLOGY | SCIE | Q3 | — | 54/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 102/187 |
| 2004 | PHYSIOLOGY | SCIE | Q2 | — | 37/74 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 94/185 |
| 2003 | PHYSIOLOGY | SCIE | Q2 | — | 35/74 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 99/188 |
| 2002 | PHYSIOLOGY | SCIE | Q3 | — | 40/73 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 88/186 |
| 2001 | PHYSIOLOGY | SCIE | Q3 | — | 39/74 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 76/181 |
| 2000 | PHYSIOLOGY | SCIE | Q2 | — | 34/76 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/175 |
| 1999 | PHYSIOLOGY | SCIE | Q3 | — | 39/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 89/178 |
| 1998 | PHYSIOLOGY | SCIE | Q3 | — | 34/67 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 96/157 |
| 1997 | PHYSIOLOGY | SCIE | Q3 | — | 39/65 |